Peer Review History

Original SubmissionAugust 22, 2021
Decision Letter - Maw Pin Tan, Editor

PONE-D-21-26434

Health equity and wellbeing among older people’s caregivers in New Zealand during COVID-19: Protocol for a qualitative study

PLOS ONE

Dear Dr. Burholt,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Maw Pin Tan, M.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is excellent and much-needed research. I congratulate the authors.

I have only one comment. In lines 413 & 414, the authors have mentioned "15 older people living with dementia, and 15 without dementia" will be selected from a convenient sample. I understand that only five caregivers from each of the three categories will be included. I wonder if this is an adequate sample. Maybe the authors should have aimed for data saturation before restricting the selection to just five from each group.

Reviewer #2: This is a valuable piece of research - thank you for the invitation to review the protocol, which is very well written and generally very sound.

I only have two principal comments:

Equity is a multi-faceted term with a number of potentially different definitions, and 'Health equity' too. What is described here looks to be 'equity of potential access to services' (demand/need perspective), rather than 'equity of health outcomes', though the two are of course ultimately related, and the latter does make a sort of appearance at some point. It also appears to include 'equity of health service provision or delivery (supplier perspective)'. The term 'Health equity' is used in the title, and the concept of inequities is mentioned throughout - fairly infrequently to be honest, given the prominence of the term in the title. However, currently, no definition is provided. This should appear early in the piece and be sufficiently detail.

The choice of the Human ecological model - as opposed to other potentially relevant frameworks or models - needs a fuller and more detailed justification.

Other comments: Abstract has too much repetition, and needs rewriting; sampling for phase I needs clarifying if it is convenient or purposive.

I have attached the pdf with some comments, typos etc.

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Sridhar Vaitheswaran

Reviewer #2: Yes: Christopher Carroll

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-21-26434_reviewer.pdf
Revision 1

Reviewer #1: This is excellent and much-needed research. I congratulate the authors.

I have only one comment. In lines 413 & 414, the authors have mentioned "15 older people living with dementia, and 15 without dementia" will be selected from a convenient sample. I understand that only five caregivers from each of the three categories will be included. I wonder if this is an adequate sample. Maybe the authors should have aimed for data saturation before restricting the selection to just five from each group.

We acknowledge that this is a limitation of our research that will be acknowledged in future publications of results from this study. Although we would have loved to have a larger sampler, the grant ceiling was NZ$250K and this was the maximum number of interviews that we could achieve (taking into account translation and transcription costs etc).

Reviewer #2:

I only have two principal comments:

Equity is a multi-faceted term with a number of potentially different definitions, and 'Health equity' too. What is described here looks to be 'equity of potential access to services' (demand/need perspective), rather than 'equity of health outcomes', though the two are of course ultimately related, and the latter does make a sort of appearance at some point. It also appears to include 'equity of health service provision or delivery (supplier perspective)'. The term 'Health equity' is used in the title, and the concept of inequities is mentioned throughout - fairly infrequently to be honest, given the prominence of the term in the title. However, currently, no definition is provided. This should appear early in the piece and be sufficiently detail.

NOTE TO EDITOR – the line numbers do not match between the tracked changes version and non-tracked version of the MS. We have not been able to resolve this issue (with a skip in numbering from 49-57 in the tracked version). The line numbers in the response to reviewers refer to the non-tracked changes version of the MS.

The following definition has been provided at the beginning of the protocol (Line 51): “Health equity has been defined as “the state in which everyone has the opportunity to obtain full health potential and no one is disadvantaged from achieving this potential because of social position or any other socially defined circumstances” [1]. The Ministry of Health in New Zealand recognises that people have differences in health that are not only avoidable but unfair and unjust. The underlying causes of health inequity are largely located outside of the typically constituted domain of “health”. However, the end result is a disproportionate burden of ill health in populations that face social, economic, cultural and political inequities. Equity recognises different people with different levels of advantage require different approaches and resources to produce equitable health outcomes.” We think that this now frames the rest of the proposal clearly delineating the difference between health equity as an ‘outcome’ and different pathways or causes of health inequity.

Two new references have been added in this paragraph:

National Academies of Sciences Engineering and Medicine Health and Medicine Division, Health and Medicine Board on Population Health and Public Health Practice, Committee on Community-Based Solutions to Promote Health Equity in the United States, Baciu A, Negussie Y, Geller A, et al. Communities in Action: Pathways to Health Equity: National Academies Press; 2017.

Ministry of Health New Zealand Government. Achieving equity: Ministry of Health New Zealand Government; 2022 [cited 2022 11 May]. Available from: https://www.health.govt.nz/about-ministry/what-we-do/work-programme-2019-20/achieving-equity#:~:text=World%20Health%20Organization.-,The%20definition,to%20get%20equitable%20health%20outcomes

(Reviewer’s comment boxes)

Is this the reference to 'health equity'? Again, there are multiple definitions of the term - what is described here looks to be like 'equity of potential access to services' (demand/need perspective), rather than 'equity of health outcomes', though the two are of course ultimately related.

The article now states that we are talking about health equity as outcomes that result from inequitable access to social, economic, cultural, political, health and social care resources, with a major focus on the latter (as relevant during the COVID 19 public health restrictions). For example, in the abstract we note: “Challenges may be especially pronounced for those experiencing inequitable access to health and social care”.

Thereafter, we clearly refer to pathways to health inequities as distinct for health inequity as an outcome:

• Line 297 “caregivers from different cultures/ethnicities, social or geographic locations experienced particular inequities in health and care provision”

• Line 338 “in danger of glossing over issues of social justice and inequity at the community level. Some communities could be described as impoverished care environments and may be least equipped to meet a such a social care agenda [130]. We need to identify inequities in health and social care support, and access to others services for caregivers in disadvantaged communities or living at a distance from ‘resource centres’”

• Line 343: “especially in areas with inequitable/sub-optimal access to health and social care”.

• Line 464 “will identify inequities in access to services (including broadband and internet services)”

• Line 606 “particularly affected by sub-optimal and inequitable access to advice, health and social care support and resources”

• Line 175 “in the context of a significant ageing population and health inequities for Māori.”

Amended line 322 “caregivers living in communities that experienced unequal access before lockdown have been pushed further to the margins.”

Amended line 343 “A critical human ecological approach provides a meta-framework for challenging health inequities”

This is now moving towards health equity in terms of health outcomes.

Line 261. In this section entitled Individual characteristics and resources influence on caregiving we note that “A large body of global research emphasises negative impacts of caregiving on physical, psychosocial, emotional, social and financial circumstances, otherwise known as ‘caregiver burden’ [118]”. Thus, ‘caregiver burden’ is not synonymous with health equity. Therefore, in this section we have highlighted ‘health equity’ in terms of health outcomes; we have also added a line to indicate that “these are the downstream corollaries of social, economic, cultural and political inequities.”

The choice of the Human ecological model - as opposed to other potentially relevant frameworks or models - needs a fuller and more detailed justification.

(Reviewer’s comment box)

Needs a reference at the end of the sentence - also the choice of this particular model needs more detailed justification. [Line 330].

Line 344, The reference for the ecological framework is in the middle of the sentence. The last part of the sentence is about the purpose of using this framework in the current study – this does not have a reference.

We have added the following statement to justify the choice of the critical human ecological framework Line 356: “The critical human ecological framework has been selected to situate this research because this approach recognizes that individuals are embedded in different intersecting settings, and that social or cultural group experiences can shape how individuals experience these settings, and ultimately health equity. Embedding experiences within larger systems of culture (macrosystem) and time (chronosystem), will be used to explicitly acknowledge issues of power, oppression and privilege, for example in the experiences of access to health and social care during the COVID19 public health restrictions.”

Other comments: Abstract has too much repetition, and needs rewriting; sampling for phase I needs clarifying if it is convenient or purposive.

(Reviewer’s comment boxes)

Deleted text describe the methods to be used, rather than the objectives, and is repeated below. Done.

Part ii - listed above - seems to be missing here. Abstract states, “and 30 representatives from organisations supporting caregivers in New Zealand will be interviewed”. Added the line “Resources that service providers had created or used for the caregivers and older people will be collated and categorised.”

Other comment boxes on pdf:

'unheard' rather than 'invisible'? Not amended. See references 20, 48, 49, 93 and 128 for the ‘invisible workforce’ that refers to the status of unpaid caregivers.

Are these 40,000 still unpaid caregivers? Or paid and unpaid? The reference given is not clear. Added ‘unpaid’ in text.

'caregivers' is unhyphenated elsewhere. Amended to caregivers throughout the manuscript.

Multiple potential definitions of this term - including, but limited to, being able to find health information, and being able to understand and action health information - maybe define for this context. Added to text. “In this context, health literacy refers to the ‘degree to which individuals have the capacity to obtain, process and understand basic health information and services needed to make appropriate health decisions’ [63].”

Is this then a convenience or a purposive sample? Line 430 has been amended to “A new cross-sectional purposive critical case sample” and reference provided. New reference added to list.

Etikan I, Musa SA, Alkassim RS. Comparison of convenience sampling and purposive sampling. Am J Theor Appl Stat. 2016;5(1):1-4. doi: 10.11648/j.ajtas.20160501.11.

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

The following statement has been added to the results section.

“Availability of data and materials

The datasets generated and/or analysed during the study will not be made publicly available as restrictions apply to the availability of these data (intention of data analysis included in participant information forms) and sensitivity (i.e. human data, Māori data sovereignty) but will be available from the corresponding author on reasonable request. Data will be located in a controlled access repository at the University of Auckland.”

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Maw Pin Tan, Editor

Health equity and wellbeing among older people’s caregivers in New Zealand during COVID-19: Protocol for a qualitative study

PONE-D-21-26434R1

Dear Dr. Burholt,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Maw Pin Tan, M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all the comments. I have no further comments. The manuscript appears ready for publication.

Reviewer #2: Revisions generally conducted in response to requests ------------------------------------------------

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Sridhar Vaitheswaran

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Maw Pin Tan, Editor

PONE-D-21-26434R1

Health equity and wellbeing among older people’s caregivers in New Zealand during COVID-19: Protocol for a qualitative study

Dear Dr. Burholt:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Maw Pin Tan

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .